documents: FDA-2016-E-2529-0008

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2016-E-2529-0008 FDA FDA-2016-E-2529 Determination of Regulatory Review Period for Purposes of Patent Extension; BRIVIACT ORAL SOLUTION, New Drug Application 205838 Notice Determinations 2019-12-12T05:00:00Z 2019 12 2019-12-12T05:00:00Z 2020-02-11T04:59:59Z 2019-12-12T14:38:30Z 2019-26814 0 0 0900006484206b7a

Links from other tables